Dr David Goldstein

Honorary Associate
Medicine, Sydney Medical School
NHMRC Clinical Trials Centre


Current national competitive grants*


Personalising care in resectable pancreas cancer. GAP-T: a study of imaging and molecular biomarkers to guide treatment of patients receiving preoperative chemotherapy followed by surgery.
Barbour A, Goldstein D, Kench J, Yip S, Brown C, Hicks R, Chang D
NHMRC Project Grants ($391,175 over 3 years)


Phase III Study in patients with Locally Advanced Pancreatic cancer: Gemcitabine +/- chemoradiotherapy and +/- erlotinib
Goldstein D, Spry N, Padbury R, Shannon J, Biankin A, Kneebone A, Fitzgerald P
Cancer Australia Priority-driven Collaborative Cancer Research Scheme ($259,000 over 6 years)

* Grants administered through the University of Sydney